Literature DB >> 12701695

A case of IgE multiple myeloma.

Lyn Lloyd, Sandra L Klingberg, Mere Kende, Jillian F Howell, Alan E Clague.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12701695

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  6 in total

1.  Bortezomib plus melphalan and prednisone (VMP regimen) as the initial treatment for IgE multiple myeloma: a case study.

Authors:  Hiroyuki Sato; Yusuke Komiya; Shigeru Hoshino
Journal:  Int J Hematol       Date:  2014-03-28       Impact factor: 2.490

2.  An unusual case of IgE-multiple myeloma presenting with systemic amyloidosis 2 years after cervical plasmacytoma resection.

Authors:  Masao Hagihara; Jian Hua; Morihiro Inoue; Naohiko Michikawa
Journal:  Int J Hematol       Date:  2010-08-10       Impact factor: 2.490

3.  Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective.

Authors:  Mariah B Pate; John Kelly Smith; David S Chi; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2010-02-23

4.  IgE myeloma with elevated level of serum CA125.

Authors:  Man-Ling Wang; Qiang Huang; Tian-Xin Yang
Journal:  J Zhejiang Univ Sci B       Date:  2009-07       Impact factor: 3.066

Review 5.  Plasma cell leukemia producing monoclonal immunoglobulin E.

Authors:  Yuzuru Takemura; Masanobu Ikeda; Kahori Kobayashi; Yuji Nakazawa; Yuichi Mori; Toshimi Mitsuishi; Hiroki Ishigame; Fumiko Kameko; Kiyotaka Fujita; Ryo Ichinohasama
Journal:  Int J Hematol       Date:  2009-08-29       Impact factor: 2.490

6.  Non-secretory immunoglobulin E myeloma associated with immunoglobulin G monoclonal gammopathy of undetermined significance.

Authors:  Masako Yasuyama; Toshie Ogasawara; Kuniaki Otsuka; Motohiko Aiba; Kiyotaka Kawauchi
Journal:  Hematol Rep       Date:  2012-07-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.